Perbedaan Organon Pharma Indonesia Tbk. dan Wahana Pronatural Tbk.: Organon Pharma Indonesia Tbk. diperdagangkan di Rp29.000 (kapitalisasi pasar 104,4 M), sedangkan Wahana Pronatural Tbk. diperdagangkan di Rp185 (kapitalisasi pasar 229,57 M, volume 24 jam 6,8 jt). Perbedaan utamanya: Wahana Pronatural Tbk. jauh lebih besar — sekitar 2,2× kapitalisasi pasar Organon Pharma Indonesia Tbk.. Mana yang lebih baik tergantung tujuan investasimu.
| SCPI | WAPO | |
|---|---|---|
Kapitalisasi Pasar | 104,4 M | 229,57 M |
Volume | — | 6,8 jt |
Lot | — | 68,05 rb |
Perputaran | — | 1,26 M |
Harga Rata-rata | — | 184,51 |
Nilai Transaksi | — | 1,26 M |
Harga Ekuilibrium Indikatif | — | 185 |
Volume Ekuilibrium Indikatif | — | 2,93 rb |
Imbal hasil berjalan pada periode standar
Berita terbaru kedua aset
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Selengkapnya di halaman SCPI →PT Wahana Phonix Mandiri (the Company) Tbk was established on August 7, 1993 under the name PT Golden Phoenix. On January 31, 2000 the Company changed its named to be PT Wahana Phonix Mandiri, Tbk. Deed by making statements shareholders meeting extraordinary No.2 on June 2, 2012 by Wachid Hasyim, notary in Surabaya, the Company name was changed to PT Wahana Pronatural Tbk
Selengkapnya di halaman WAPO →